Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 1, 2012, Pages 97-100

  Wu, Jia Feng ^a   Su, Yu Ru ^b   Chen, Chen Hsin ^c   Chen, Huey Ling ^a   Ni, Yen Hsuan ^a   Hsu, Hong Yuan ^a   Wang, Jane Ling ^b   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

alanine aminotransferase; hepatitis B e antigen; hepatitis B virus; liver immunology

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHRONIC HEPATITIS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEROCONVERSION;

ADOLESCENT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INFLAMMATION; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES;

HEPATITIS B VIRUS;

EID: 84855357930     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31822a033e     Document Type: Article

References (25)

1. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33.
2. Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol 2010;25:19-25.
3. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986;6:167-72. (Pubitemid 16144862)
4. Ni YH, Chang MH, Chen PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007;132:2340-5.
5. Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 2007;14:147-52.
6. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168-74.
7. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9.
8. Wu JF, Chen CH, Chang MH, et al. HLA typing associated with hepatitis B e antigen seroconversion in children with chronic hepatitis B virus infection: A long-term prospective sibling cohort study in Taiwan. J Pediatr 2006;148:647-51.
9. Wu JF, Wu TC, Chen CH, et al. Serum levels of interleukin 10 and 12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 2010;138:165-72.
10. Wu JF, Tsai WY, Hsu HY, et al. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men. Gastroenterology 2010;138:942-8.
11. Schwimmer JB, Dunn W, Norman GJ, et al. Safety study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010;138:1357-64.
12. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. 2nd ed. New York: Springer-Verlag; 2003.
13. Prati D, Taioli E, Zanella A, et al. Update definitions of health ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137: 1-10.
14. D'Amico A, Chen M, Roeh K, et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004;351:125-35.
15. Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-20.
16. Liaw YF, Lau GK, Kao JH, et al. Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus infection. Dig Dis Sci 2010;55:2727-34.
17. Ni YH, Chang MH, Chen PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007;132:2340-5.
18. You H, Ma H, Liu T, et al. Different models of HBeAg seroconversion predicted by on-treatment ALT and HBV DNA profiles. J Viral Hepat 2009;16:876-82.
19. Yuen MF, Fung J, Seto WK, et al. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy. Antivir Ther 2009;14:679-85.
20. Wu IC, Lai CL, Han SH, et al. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy proven histological damage. Hepatology 2010;51:1185-9.
21. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:1-36.
22. Isogawa M, Furuichi Y, Chisari FV. Oscillating CD8(+) T cell effector functions after antigen recognitation in the liver. Immunity 2005;23:53-6.
23. Stute W, Wang JL. The central limit theorem under random truncation. Bernoulli 2008;14:604-22.
24. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556-662.
25. Marx G, Martin SR, Chicoine JF, et al. Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 2002;186:295-301. (Pubitemid 34816312)